WENDY L DIXON
CIK 1202283 · last filed 2025-05-30
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.42M
Companies
13
Total Filings
145
Lifetime Open-Market Net
-$7.76M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ZVRA | Director | — | $12.65 | — | $0 | 3 | 2025-05-30 |
| BDTX | Director | 38,054 | $1.75 | $66.6K | $0 | 12 | 2024-04-03 |
| ARVN | Director | 9,121 | $7.58 | $69.1K | $0 | 4 | 2023-06-20 |
| ALKS | Director | 53,124 | $44.28 | $2.35M | -$1.05M | 21 | 2022-06-16 |
| IOVA | Director | — | $4.08 | — | $0 | 1 | 2022-06-14 |
| INCY | Director | 17,768 | $108.53 | $1.93M | -$6.71M | 43 | 2022-04-04 |
| bluebird bio, Inc. (BLUE) Delisted | Director | 11,894 | $4.97 | $59.1K | $0 | 8 | 2021-11-17 |
| VYGR | Director | — | $3.50 | — | $0 | 5 | 2020-06-05 |
| Carisma Therapeutics Inc. (SESN) Delisted | Director | — | $12.58 | — | $0 | 2 | 2019-06-21 |
| Carisma Therapeutics Inc. (EBIO) Delisted | Director | — | — | — | $0 | 4 | 2017-05-23 |
| Orexigen Therapeutics, Inc. (OREX) Delisted | Director | — | — | — | $0 | 6 | 2015-06-10 |
| Furiex Pharmaceuticals, Inc. (FURX) Delisted | Director | 7,160 | — | — | $0 | 7 | 2014-03-04 |
| Ardea Biosciences, Inc./DE (RDEA) Delisted | Director | — | — | — | $0 | 3 | 2012-06-20 |
Recent Filings · Page 4 of 15
145 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-05-28 | INCY | Grant (A) | +1,923 | $0 | EDGAR |
| 2021-05-21 | ALKS | Mixed | +4,700 | -$30.8K | EDGAR |
| 2021-04-20 | ALKS | Mixed | — | -$135.1K | EDGAR |
| 2021-04-01 | INCY | Grant (A) | +225 | $18.3K | EDGAR |
| 2021-01-15 | ALKS | Exer (M) | +35,000 | $441.7K | EDGAR |
| 2021-01-05 | INCY | Grant (A) | +213 | $18.5K | EDGAR |
| 2020-12-04 | ALKS | Grant (A) | — | $0 | EDGAR |
| 2020-10-01 | INCY | Grant (A) | +197 | $17.7K | EDGAR |
| 2020-08-31 | INCY | Mixed | — | -$1.51M | EDGAR |
| 2020-07-01 | INCY | Grant (A) | +182 | $18.9K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.